GT-200

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameGT-200
Drug Alias NameGT200
ClassificationBiologics > T cell engagers
Mechanisms of Action6-Sulfo LacNAc inhibitors
Targets6-Sulfo LacNAc
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesScancell
China Registration ClassN/A

Develop Information

Active CompaniesScancell
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A